Clinical validation of a serum protein biomarker signature for the early diagnosis of pancreatic cancer.

Informazioni relative al progetto

IMMPACT

ID dell’accordo di sovvenzione: 672454

DOI

10.3030/672454

Progetto chiuso

Data della firma CE 15 Luglio 2015

Data di avvio 1 Giugno 2015

Data di completamento 31 Maggio 2018

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale

€ 4 244 969,25

Contributo UE

€ 4 244 969,00

Coordinato da

IMMUNOVIA AB
Sweden

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Other (1)

Simplified user interface

Documents, reports (5)

Interim prospective validation report

An interim report will be generated after 18 months into the study to make any necessary adjustments to the study and present the first validation results. This interim report will conclude the requested support from SME-instrument, though the study will continue for yet another 18 months to finalize the study.

Retrospective clinical study report OHSU Study

Retrospective clinical study report OHSU Study retrospective clinical investigation nr 2

Retrospective clinical study report Herlev Study

Retrospective clinical study report Herlev Study retrospective clinical investigation nr 1

Retrospective clinical study report OXFORD Study

Retrospective clinical study report OXFORD Study (retrospective clinical investigation nr 4)

Retrospective clinical study report PANCAN Study

Retrospective clinical study report PANCAN Study (retrospective clinical investigation nr 3)

Websites, patent fillings, videos etc. (1)

Project website